Vanderbilt mourns loss of renowned scientist Exton

John H. Exton, MBChB, MD, PhD, professor of Molecular Physiology and Biophysics, emeritus at Vanderbilt University, whose research provided fundamental insights into how many biologically active compounds control cellular physiology, died Dec. 18. He was 89.

VUMC Announces VICTR Leadership Transition

Novel therapeutic target identified for chronic kidney disease

Vanderbilt investigators have discovered a molecular mechanism that promotes chronic kidney disease following kidney injury.

Reduced kidney function may cause cardiovascular disease: study

An international team of investigators has found that mild to moderate reduction in kidney function may cause cardiovascular disease, even in people without symptoms of heart disease or diabetes.

Dooley honored by Treatment Action Group

Vanderbilt’s Kelly Dooley, MD, PhD, MPH, recently received the Research in Action Award from the Treatment Action Group (TAG).

Surgical risk persists for patients who’ve had COVID

Vanderbilt researchers report that the trend of decreasing postoperative risk for people who have had COVID persists longer than previously known, for as long as 13 months after COVID.